The lung is a megakaryocyte outpost that can defend against thrombocytopenic attack
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci186111 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Anthony K Yeung und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, UCSF, San Francisco, California, USA. Hauptthemen laut MEDLINE: Megakaryocytes, Thrombocytopenia, Lung. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatrics, UCSF, San Francisco, California, USA.
- Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, Massachusetts, USA.
- Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, Massachusetts, USA.
Zitieren
APA
Yeung, A. K., & Murphy, G. J. (2024). The lung is a megakaryocyte outpost that can defend against thrombocytopenic attack. Journal of Clinical Investigation. https://doi.org/10.1172/jci186111
Vancouver
Yeung AK, Murphy GJ. The lung is a megakaryocyte outpost that can defend against thrombocytopenic attack. Journal of Clinical Investigation. 2024. doi:10.1172/jci186111
BibTeX
@article{Yeung2024,
author = {Yeung, Anthony K and Murphy, George J},
title = {The lung is a megakaryocyte outpost that can defend against thrombocytopenic attack},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci186111}
}
EUVIMED